Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study

{ 'indexed': { 'date-parts': [[2023, 11, 30]], 'date-time': '2023-11-30T16:20:05Z', 'timestamp': 1701361205688}, 'reference-count': 42, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2021, 1, 1]], 'date-time': '2021-01-01T00:00:00Z', 'timestamp': 1609459200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2020, 10, 22]], 'date-time': '2020-10-22T00:00:00Z', 'timestamp': 1603324800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'funder': [ { 'DOI': '10.13039/501100006107', 'name': 'Gil Medical Center, Gachon University', 'doi-asserted-by': 'publisher'}, { 'DOI': '10.13039/501100003725', 'name': 'National Research Foundation of Korea', 'doi-asserted-by': 'publisher'}], 'content-domain': { 'domain': [ 'ijidonline.com', 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.fr', 'clinicalkey.com.au', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 1]]}, 'DOI': '10.1016/j.ijid.2020.10.062', 'type': 'journal-article', 'created': { 'date-parts': [[2020, 10, 27]], 'date-time': '2020-10-27T17:09:28Z', 'timestamp': 1603818568000}, 'page': '275-281', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 8, 'title': 'Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir ' 'versus hydroxychloroquine: A nationwide propensity score-matched cohort study', 'prefix': '10.1016', 'volume': '102', 'author': [ {'given': 'Min Joo', 'family': 'Choi', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-9428-0258', 'authenticated-orcid': False, 'given': 'Minsun', 'family': 'Kang', 'sequence': 'additional', 'affiliation': []}, {'given': 'So Youn', 'family': 'Shin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ji Yun', 'family': 'Noh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hee Jin', 'family': 'Cheong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Woo Joo', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4856-3668', 'authenticated-orcid': False, 'given': 'Jaehun', 'family': 'Jung', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-0148-7194', 'authenticated-orcid': False, 'given': 'Joon Young', 'family': 'Song', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ijid.2020.10.062_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '396', 'DOI': '10.1016/j.ijid.2020.06.099', 'article-title': 'Treatment with hydroxychloroquine, azithromycin, and combination in ' 'patients hospitalized with COVID-19', 'volume': '97', 'author': 'Arshad', 'year': '2020', 'journal-title': 'Int J Infect Dis'}, { 'issue': '14', 'key': '10.1016/j.ijid.2020.10.062_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '1406', 'DOI': '10.1001/jama.2020.2565', 'article-title': 'Presumed asymptomatic carrier transmission of COVID-19', 'volume': '323', 'author': 'Bai', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '11', 'key': '10.1016/j.ijid.2020.10.062_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '2317', 'DOI': '10.1093/cid/ciz634', 'article-title': 'Effect of oral oseltamivir on virological outcomes in low-risk adults ' 'with influenza: a randomized clinical trial', 'volume': '70', 'author': 'Beigel', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'issue': '4', 'key': '10.1016/j.ijid.2020.10.062_bib0020', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamanetworkopen.2020.8857', 'article-title': 'Effect of high vs low doses of chloroquine diphosphate as adjunctive ' 'therapy for patients hospitalized with severe acute respiratory ' 'syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical ' 'trial', 'volume': '3', 'author': 'Borba', 'year': '2020', 'journal-title': 'JAMA Netw Open'}, { 'issue': '19', 'key': '10.1016/j.ijid.2020.10.062_bib0025', 'doi-asserted-by': 'crossref', 'first-page': '1787', 'DOI': '10.1056/NEJMoa2001282', 'article-title': 'A trial of lopinavir-ritonavir in adults hospitalized with severe ' 'Covid-19', 'volume': '382', 'author': 'Cao', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '4', 'key': '10.1016/j.ijid.2020.10.062_bib0030', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.106144', 'article-title': 'Low-dose hydroxychloroquine therapy and mortality in hospitalised ' 'patients with COVID-19: a nationwide observational study of 8075 ' 'participants', 'volume': '56', 'author': 'Catteau', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0035', 'series-title': 'Interim clinical guidance for management of patients with confirmed ' 'coronavirus disease (COVID-19)', 'author': 'Centers for Disease Control and Prevention (CDC)', 'year': '2020'}, { 'issue': '3', 'key': '10.1016/j.ijid.2020.10.062_bib0040', 'doi-asserted-by': 'crossref', 'first-page': '413', 'DOI': '10.1016/j.bbrc.2020.05.203', 'article-title': 'Altered COVID-19 receptor ACE2 expression in a higher risk group for ' 'cerebrovascular disease and ischemic stroke', 'volume': '528', 'author': 'Choi', 'year': '2020', 'journal-title': 'Biochem Biophys Res Commun'}, { 'issue': '10', 'key': '10.1016/j.ijid.2020.10.062_bib0045', 'doi-asserted-by': 'crossref', 'DOI': '10.3201/eid2610.201539', 'article-title': 'Community treatment centers for isolation of asymptomatic and mildly ' 'symptomatic patients with coronavirus disease, South Korea', 'volume': '26', 'author': 'Choi', 'year': '2020', 'journal-title': 'Emerg Infect Dis'}, { 'issue': '3', 'key': '10.1016/j.ijid.2020.10.062_bib0050', 'doi-asserted-by': 'crossref', 'first-page': '252', 'DOI': '10.1136/thorax.2003.012658', 'article-title': 'Role of lopinavir/ritonavir in the treatment of SARS: initial ' 'virological and clinical findings', 'volume': '59', 'author': 'Chu', 'year': '2004', 'journal-title': 'Thorax'}, { 'issue': '20', 'key': '10.1016/j.ijid.2020.10.062_bib0055', 'first-page': '30335', 'article-title': 'Use of hydroxychloroquine in hospitalized COVID-19 patients is ' 'associated with reduced mortality: Findings from the observational ' 'multicentre Italian CORIST study', 'volume': 'S0953-6205', 'author': 'COVID-19 RISK', 'year': '2020', 'journal-title': 'Eur J Intern Med'}, { 'issue': '6', 'key': '10.1016/j.ijid.2020.10.062_bib0060', 'doi-asserted-by': 'crossref', 'first-page': '491', 'DOI': '10.1016/j.recesp.2017.03.006', 'article-title': 'Dilated cardiomyopathy and hydroxychloroquine-induced phospholipidosis: ' 'from curvilinear bodies to clinical suspicion', 'volume': '71', 'author': 'Di Girolamo', 'year': '2018', 'journal-title': 'Rev Esp Cardiol'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.10.062_bib0065', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s13568-020-01028-0', 'article-title': 'The role of environmental factors to transmission of SARS-CoV-2 ' '(COVID-19)', 'volume': '10', 'author': 'Eslami', 'year': '2020', 'journal-title': 'AMB Express'}, { 'issue': '17', 'key': '10.1016/j.ijid.2020.10.062_bib0070', 'doi-asserted-by': 'crossref', 'first-page': '2625', 'DOI': '10.1097/QAD.0000000000000421', 'article-title': 'Long-acting three-drug combination anti-HIV nanoparticles enhance drug ' 'exposure in primate plasma and cells within lymph nodes and blood', 'volume': '28', 'author': 'Freeling', 'year': '2014', 'journal-title': 'AIDS'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.10.062_bib0075', 'doi-asserted-by': 'crossref', 'DOI': '10.1183/13993003.01190-2020', 'article-title': 'Risk factors for viral RNA shedding in COVID-19 patients', 'volume': '56', 'author': 'Fu', 'year': '2020', 'journal-title': 'Eur Respir J'}, { 'issue': '22', 'key': '10.1016/j.ijid.2020.10.062_bib0080', 'doi-asserted-by': 'crossref', 'first-page': '2158', 'DOI': '10.1056/NEJMe2009758', 'article-title': 'Asymptomatic transmission, the Achilles’ heel of current strategies to ' 'control Covid-19', 'volume': '382', 'author': 'Gandhi', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0085', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '4', 'key': '10.1016/j.ijid.2020.10.062_bib0090', 'doi-asserted-by': 'crossref', 'first-page': '322', 'DOI': '10.1093/jmcb/mjaa014', 'article-title': 'Treating COVID-19 with chloroquine', 'volume': '12', 'author': 'Huang', 'year': '2020', 'journal-title': 'J Mol Cell Biol'}, { 'issue': '10238', 'key': '10.1016/j.ijid.2020.10.062_bib0095', 'doi-asserted-by': 'crossref', 'first-page': '1695', 'DOI': '10.1016/S0140-6736(20)31042-4', 'article-title': 'Triple combination of interferon beta-1b, lopinavir-ritonavir, and ' 'ribavirin in the treatment of patients admitted to hospital with ' 'COVID-19: an open-label, randomised, phase 2 trial', 'volume': '395', 'author': 'Hung', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': '4', 'key': '10.1016/j.ijid.2020.10.062_bib0100', 'doi-asserted-by': 'crossref', 'first-page': '782', 'DOI': '10.3904/kjim.2020.157', 'article-title': 'In vitro activity of lopinavir/ritonavir and hydroxychloroquine against ' 'severe acute respiratory syndrome coronavirus 2 at concentrations ' 'achievable by usual doses', 'volume': '35', 'author': 'Kang', 'year': '2020', 'journal-title': 'Korean J Intern Med'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.10.062_bib0105', 'doi-asserted-by': 'crossref', 'first-page': '264', 'DOI': '10.1016/j.bbrc.2004.08.085', 'article-title': 'In vitro inhibition of severe acute respiratory syndrome coronavirus by ' 'chloroquine', 'volume': '323', 'author': 'Keyaerts', 'year': '2004', 'journal-title': 'Biochem Biophys Res Commun'}, { 'issue': '2', 'key': '10.1016/j.ijid.2020.10.062_bib0110', 'doi-asserted-by': 'crossref', 'first-page': '281', 'DOI': '10.3947/ic.2020.52.2.281', 'article-title': 'Interim guidelines on antiviral therapy for COVID-19', 'volume': '52', 'author': 'Kim', 'year': '2020', 'journal-title': 'Infect Chemother'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0115', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.mehy.2020.109783', 'article-title': 'Hydroxychloroquine as an aerosol might markedly reduce and even prevent ' 'severe clinical symptoms after SARS-CoV-2 infection', 'volume': '142', 'author': 'Klimke', 'year': '2020', 'journal-title': 'Med Hypotheses'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0120', 'series-title': 'Infection control guidlines for healthcare professional about COVID-19', 'author': 'Korea Centers for Disease Control and Prevention', 'year': '2020'}, { 'issue': '10', 'key': '10.1016/j.ijid.2020.10.062_bib0125', 'doi-asserted-by': 'crossref', 'DOI': '10.3201/eid2610.201620', 'article-title': 'Clinical course of asymptomatic and mildly symptomatic patients with ' 'coronavirus disease admitted to community treatment centers, South ' 'Korea', 'volume': '26', 'author': 'Lee', 'year': '2020', 'journal-title': 'Emerg Infect Dis'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0130', 'article-title': 'An exploratory randomized controlled study on the efficacy and safety ' 'of lopinavir/ritonavir or arbidol treating adult patients hospitalized ' 'with mild/moderate COVID-19 (ELACOI)', 'author': 'Li', 'year': '2020', 'journal-title': 'medRxiv'}, { 'issue': '7', 'key': '10.1016/j.ijid.2020.10.062_bib0135', 'doi-asserted-by': 'crossref', 'first-page': '831', 'DOI': '10.1001/jamacardio.2020.1286', 'article-title': 'Potential effects of coronaviruses on the cardiovascular system: a ' 'review', 'volume': '5', 'author': 'Madjid', 'year': '2020', 'journal-title': 'JAMA Cardiol'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0140', 'doi-asserted-by': 'crossref', 'first-page': 'e202422', 'DOI': '10.1001/jamapediatrics.2020.2422', 'article-title': 'Simulated assessment of pharmacokinetically guided dosing for ' 'investigational treatments of pediatric patients with coronavirus ' 'disease 2019', 'author': 'Maharaj', 'year': '2020', 'journal-title': 'JAMA Pediatr'}, { 'issue': '10240', 'key': '10.1016/j.ijid.2020.10.062_bib0145', 'doi-asserted-by': 'crossref', 'first-page': '1820', 'DOI': '10.1016/S0140-6736(20)31324-6', 'article-title': 'Retraction-hydroxychloroquine or chloroquine with or without a ' 'macrolide for treatment of COVID-19: a multinational registry analysis', 'volume': '395', 'author': 'Mehra', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.10.062_bib0150', 'doi-asserted-by': 'crossref', 'first-page': '140', 'DOI': '10.1186/1471-2334-11-140', 'article-title': 'Duration of viral shedding in hospitalized patients infected with ' 'pandemic H1N1', 'volume': '11', 'author': 'Meschi', 'year': '2011', 'journal-title': 'BMC Infect Dis'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0155', 'first-page': '1', 'article-title': 'Risk factors for mortality in patients with COVID-19 in New York City', 'author': 'Mikami', 'year': '2020', 'journal-title': 'J Gen Intern Med'}, { 'issue': '5', 'key': '10.1016/j.ijid.2020.10.062_bib0160', 'doi-asserted-by': 'crossref', 'first-page': '816', 'DOI': '10.1016/j.jinf.2020.05.035', 'article-title': 'Asymptomatic infection and atypical manifestations of COVID-19: ' 'comparison of viral shedding duration', 'volume': '81', 'author': 'Noh', 'year': '2020', 'journal-title': 'J Infect'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0165', 'doi-asserted-by': 'crossref', 'first-page': '336', 'DOI': '10.1016/j.semarthrit.2003.09.012', 'article-title': 'Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a ' 'report of 2 cases and review of the literature', 'author': 'Nord', 'year': '2004', 'journal-title': 'Semin Arthritis Rheum'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0170', 'first-page': '1', 'article-title': 'Lower COVID-19 mortality in Italian forested areas suggests ' 'immunoprotection by mediterranean plants', 'author': 'Roviello', 'year': '2020', 'journal-title': 'Environ Chem Lett'}, { 'issue': '10', 'key': '10.1016/j.ijid.2020.10.062_bib0175', 'doi-asserted-by': 'crossref', 'DOI': '10.3201/eid2610.201886', 'article-title': 'Effect of nonpharmaceutical interventions on transmission of severe ' 'acute respiratory syndrome coronavirus 2, South Korea, 2020', 'volume': '26', 'author': 'Ryu', 'year': '2020', 'journal-title': 'Emerg Infect Dis'}, { 'issue': '18', 'key': '10.1016/j.ijid.2020.10.062_bib0180', 'first-page': '1824', 'article-title': 'Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a ' 'review', 'volume': '323', 'author': 'Sanders', 'year': '2019', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0185', 'doi-asserted-by': 'crossref', 'first-page': 'm1849', 'DOI': '10.1136/bmj.m1849', 'article-title': 'Hydroxychloroquine in patients with mainly mild to moderate coronavirus ' 'disease 2019: open label, randomised controlled trial', 'volume': '369', 'author': 'Tang', 'year': '2020', 'journal-title': 'BMJ'}, { 'issue': '4', 'key': '10.1016/j.ijid.2020.10.062_bib0190', 'doi-asserted-by': 'crossref', 'first-page': '313', 'DOI': '10.1016/j.jpha.2020.03.009', 'article-title': 'Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug ' 'discovery from medicinal plants', 'volume': '10', 'author': 'Ul Qamar', 'year': '2020', 'journal-title': 'J Pharm Anal'}, { 'issue': '3', 'key': '10.1016/j.ijid.2020.10.062_bib0195', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0200', 'series-title': 'Coronavirus disease (COVID-19) weekly epidemiological update, 12 October ' '2020', 'author': 'WHO', 'year': '2020'}, { 'issue': '1', 'key': '10.1016/j.ijid.2020.10.062_bib0205', 'doi-asserted-by': 'crossref', 'first-page': '2000799', 'DOI': '10.1183/13993003.00799-2020', 'article-title': 'Factors associated with prolonged viral shedding and impact of ' 'lopinavir/ritonavir treatment in hospitalised non-critically ill ' 'patients with SARS-CoV-2 infection', 'volume': '56', 'author': 'Yan', 'year': '2020', 'journal-title': 'Eur Respir J'}, { 'key': '10.1016/j.ijid.2020.10.062_bib0210', 'article-title': 'Prolonged SARS-CoV-2 viral shedding in patients with COVID-19 was ' 'associated with delayed initiation of arbidol treatment: a ' 'retrospective cohort study', 'author': 'Zhou', 'year': '2020', 'journal-title': 'MedRxiv'}], 'container-title': 'International Journal of Infectious Diseases', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1201971220322669?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1201971220322669?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 4, 21]], 'date-time': '2021-04-21T21:28:58Z', 'timestamp': 1619040538000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1201971220322669'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 1]]}, 'references-count': 42, 'alternative-id': ['S1201971220322669'], 'URL': 'http://dx.doi.org/10.1016/j.ijid.2020.10.062', 'relation': {}, 'ISSN': ['1201-9712'], 'subject': ['Infectious Diseases', 'Microbiology (medical)', 'General Medicine'], 'container-title-short': 'International Journal of Infectious Diseases', 'published': {'date-parts': [[2021, 1]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Comparison of antiviral effect for mild-to-moderate COVID-19 cases between ' 'lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity ' 'score-matched cohort study', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'International Journal of Infectious Diseases', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ijid.2020.10.062', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 The Author(s). Published by Elsevier Ltd on behalf of International ' 'Society for Infectious Diseases.', 'name': 'copyright', 'label': 'Copyright'}]}